Alector Inc
(STU:0Z2)
€
1.293
-0.022 (-1.67%)
Market Cap: 144.44 Mil
Enterprise Value: -6.72 Mil
PE Ratio: 0
PB Ratio: 15.74
GF Score: 34/100 H.C. Wainwright with Alector Transcript
May 24, 2023 / 03:00PM GMT
Release Date Price:
€7
(-2.78%)
Ananda Kumar Ghosh
H.C. Wainwright & Co, LLC, Research Division - Analyst
Good morning. I welcome you all to today's fireside chat with Alector, a neuroscience company that aims to harness the power of neuroinflammation to combat neuroinflammation. Today, we have with us Alector's CEO, Arnon Rosenthal; and CFO, Marc Grasso. So.
Marc Grasso
Alector, Inc. - CFO, Principal Financial Officer & Principal Accounting Officer
Hi, Ananda, pleasure to be here with you.
Ananda Kumar Ghosh
H.C. Wainwright & Co, LLC, Research Division - Analyst
Sorry, there is some background happening. Are we good now?
Marc Grasso
Alector, Inc. - CFO, Principal Financial Officer & Principal Accounting Officer
I can hear you loud and clear.
Ananda Kumar Ghosh
H.C. Wainwright & Co, LLC, Research Division - Analyst
Okay. So let me just start begin with asking you -- Hi, (inaudible) there is some feedback, which I'm getting. Okay.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot